Inflammation and depression.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Current topics in behavioral neurosciences

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/7854_2012_211PMID 22553073
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis

  2012cited by this paper
• Depressive-like behavior induced by tumor necrosis factor-α in mice.

  2012cited by this paper
• Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis.

  2012cited by this paper
• Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression.

  2012cited by this paper
• Immune suppression and immune activation in depression.

  2011cited by this paper
• Association of a Polymorphism in the Indoleamine-2,3-Dioxygenase Gene and Interferon-α-Induced Depression in Patients with Chronic Hepatitis C

  2011cited by this paper
• Depression and risk of developing dementia

  2011cited by this paper
• The efficacy of omega-3 supplementation for major depression: a randomized controlled trial.

  2011cited by this paper
• Glucocorticoids, cytokines and brain abnormalities in depression.

  2011cited by this paper
• Cytokines mediated inflammation and decreased neurogenesis in animal models of depression.

  2011cited by this paper
• Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of Research

  2011cited by this paper
• Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.

  2011cited by this paper
• Constant Darkness Induces IL-6-Dependent Depression-Like Behavior through the NF-κB Signaling Pathway

  2011cited by this paper
• Citalopram reduces endotoxin-induced fatigue.

  2011cited by this paper
• Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels.

  2010cited by this paper
• Interferon-α effects on diurnal hypothalamic–pituitary–adrenal axis activity: relationship with proinflammatory cytokines and behavior

  2010cited by this paper
• Long chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly depression: Effects on depressive symptoms, on phospholipids fatty acids profile and on health-related quality of life

  2010cited by this paper
• ALTERED EXPRESSION OF GENES INVOLVED IN INFLAMMATION AND APOPTOSIS IN FRONTAL CORTEX IN MAJOR DEPRESSION

  2010cited by this paper
• A meta-analysis of cytokines in major depression.

  2010cited by this paper
• Association of high-sensitivity C-reactive protein with de novo major depression

  2010cited by this paper
• Interleukin-1 Receptor Activation by Systemic Lipopolysaccharide Induces Behavioral Despair Linked to MAPK Regulation of CNS Serotonin Transporters

  2010cited by this paper
• Enhanced IL‐1β production in response to the activation of hippocampal glial cells impairs neurogenesis in aged mice

  2010cited by this paper
• The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression.

  2010cited by this paper
• Association between Plasma IL-6 Response to Acute Stress and Early-Life Adversity in Healthy Adults

  2010cited by this paper
• Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward.

  2010cited by this paper
• Hippocampal epigenetic modification at the doublecortin gene is involved in the impairment of neurogenesis with aging

  2010cited by this paper
• Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood.

  2010cited by this paper
• Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.

  2009cited by this paper
• Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality.

  2009cited by this paper
• Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory.

  2009cited by this paper
• Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.

  2009cited by this paper
• Biological Mechanism of Antidepressant Effect of Omega–3 Fatty Acids: How Does Fish Oil Act as a ‘Mind-Body Interface’?

  2009cited by this paper
• The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

  2009cited by this paper
• Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice

  2009cited by this paper
• Emerging role of glutamate in the pathophysiology of major depressive disorder.

  2009cited by this paper
• CSF Concentrations of Brain Tryptophan and Kynurenines during Immune Stimulation with IFN-alpha: Relationship to CNS Immune Responses and Depression

  2009cited by this paper
• Evidence for a cytokine model of cognitive function.

  2009cited by this paper
• Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

  2009cited by this paper
• Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment

  2009cited by this paper
• In vitro modulation of the glucocorticoid receptor by antidepressants

  2008cited by this paper
• A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling.

  2008cited by this paper
• Inflammation, Glutamate, and Glia in Depression: A Literature Review

  2008cited by this paper
• Peripheral Inflammation is Associated with Altered Substantia Nigra Activity and Psychomotor Slowing in Humans

  2008cited by this paper
• Differential effects of interleukin-1 alpha and beta on interleukin-6 and chemokine synthesis in neurones.

  2008cited by this paper
• From inflammation to sickness and depression: when the immune system subjugates the brain

  2008cited by this paper
• Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders.

  2008cited by this paper
• Omega-3 fatty acids on the forced-swimming test.

  2008cited by this paper
• Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study.

  2008cited by this paper
• Inflammation versus glucocorticoids as purveyors of pathology during stress: have we reached the tipping point?

  2008cited by this paper
• Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression

  2008cited by this paper
• Intrahippocampal Transplantation of Transgenic Neural Precursor Cells Overexpressing Interleukin-1 Receptor Antagonist Blocks Chronic Isolation-Induced Impairment in Memory and Neurogenesis

  2008cited by this paper
• IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress

  2008cited by this paper
• Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being.

  2008cited by this paper
• Elevated inflammation levels in depressed adults with a history of childhood maltreatment.

  2008cited by this paper
• Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression.

  2007cited by this paper
• Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol.

  2007cited by this paper
• Early-life psychological stress exacerbates adult mouse asthma via the hypothalamus-pituitary-adrenal axis.

  2007cited by this paper
• Kynurenine pathway in major depression: evidence of impaired neuroprotection.

  2007cited by this paper
• Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression.

  2007cited by this paper
• A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.

  2007cited by this paper
• The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

  2007cited by this paper
• Inflammation, Depression and Dementia: Are they Connected?

  2007cited by this paper
• Depression following pegylated interferon-alpha: characteristics and vulnerability.

  2007cited by this paper
• Effects of cytokines and infections on brain neurochemistry.

  2006cited by this paper
• Cytokines sing the blues: inflammation and the pathogenesis of depression.

  2006cited by this paper
• Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.

  2006cited by this paper
• Interferon-Induced Depression in Chronic Hepatitis C: A Review of Its Prevalence, Risk Factors, Biology, and Treatment Approaches

  2006cited by this paper
• The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

  2006cited by this paper
• NF-κB and the immune response

  2006cited by this paper
• Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study

  2006cited by this paper
• The glucocorticoid receptor: part of the solution or part of the problem?

  2006cited by this paper
• Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

  2006cited by this paper
• NF-kappaB and the immune response.

  2006cited by this paper
• Increased Stress-Induced Inflammatory Responses in Male Patients With Major Depression and Increased Early Life Stress

  2006cited by this paper
• The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity.

  2005cited by this paper
• TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition.

  2005cited by this paper
• Acute inflammation and negative mood: mediation by cytokine activation.

  2005cited by this paper
• Neuropsychiatric adverse effects of interferon-alpha: recognition and management.

  2005cited by this paper
• IDO and interferon-α-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity

  2005cited by this paper
• Antiinflammatory action of glucocorticoids--new mechanisms for old drugs.

  2005cited by this paper
• Hypothesis: Cytokines may be activated to cause depressive illness and chronic fatigue syndrome

  2005cited by this paper
• Psychopathological symptoms during interferon-α and ribavirin treatment: effects on virologic response

  2005cited by this paper
• Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression.

  2005cited by this paper
• Cytokines and major depression.

  2005cited by this paper
• Neuropsychiatric Adverse Effects of Interferon-α

  2005cited by this paper
• TNFα potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NFκB inhibition

  2005cited by this paper
• Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity.

  2004cited by this paper
• Cytokines and psychopathology: lessons from interferon-alpha.

  2004cited by this paper
• Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells.

  2003cited by this paper
• Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood-brain barrier.

  2003cited by this paper
• Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression.

  2003cited by this paper
• Depression, Stress and the Adrenal axis

  2003cited by this paper
• Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects.

  2003cited by this paper
• The inflammatory response is an integral part of the stress response: Implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X.

  2003cited by this paper
• Interferon-γ-Induced Conversion of Tryptophan: Immunologic and Neuropsychiatric Aspects

  2003cited by this paper
• Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene

  2003cited by this paper
• Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.

  2003cited by this paper
• Brain interleukin-1 is involved in spatial memory and passive avoidance conditioning.

  2002cited by this paper
• Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy

  2002cited by this paper
• Increased Depressive Ratings in Patients With Hepatitis C Receiving Interferon-α–Based Immunotherapy Are Related to Interferon-α–Induced Changes in the Serotonergic System

  2002cited by this paper

• Comparing plasma levels and ratios of tryptophan, serotonin, kynurenine and quinolinic acid between patients with bipolar disorder and healthy controls: impact of depressive episode or post-traumatic stress disorder symptoms

  2026cites this paper
• The Effect of Curcumin Plus Piperine on Mental Health Status, Sleep Quality, and Anthropometric Indices in Patients with Non-Proliferative Diabetic Retinopathy: A Randomized Double-Blind Placebo-Controlled Trial

  2026cites this paper
• Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression

  2025cites this paper
• New perspectives on galectin in major depressive disorder treatment.

  2025cites this paper
• Association of clinical and sonographic factors with discrepancy between patients' and evaluators' global assessments in psoriatic arthritis.

  2025cites this paper
• Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative review

  2025cites this paper
• Associations between prenatal inflammation and dimensions of depressive symptoms across the perinatal period.

  2025cites this paper
• Neurotransmitter and metabolic effects of interferon-alpha in association with decreased striatal dopamine in a Non-Human primate model of Cytokine-Induced depression.

  2025cites this paper
• Effects of intracerebroventricular lipopolysaccharide administration on behavioral, neurochemical, and neurogenomic responses in adult zebrafish.

  2025cites this paper
• Beyond Diabetes: Semaglutide's Role in Modulating Mood Disorders through Neuroinflammation Pathways

  2025cites this paper
• The Effect of Ketamine on the Immune System in Patients with Treatment-Resistant Depression

  2025cites this paper
• The mediating role of CRP in the relationship between physical activity and depression: A nonlinear analysis.

  2025cites this paper
• The effects and mechanisms of Far-infrared ray on depression-like behavior induced by CRS in mice.

  2025cites this paper
• Association between the Alpha-1-acid glycoprotein concentrations and depression in US adult women: a cross-sectional study from NHANES 2021–2023

  2025cites this paper
• Longitudinal association between somatic symptoms and suicidal ideation in adults with major depressive disorder

  2025cites this paper
• The synergistic effect of insomnia and depression on risk of herpes zoster

  2024cites this paper
• C-Reactive Protein Does Not Predict Future Depression Onset in Adolescents: Preliminary Findings from a Longitudinal Study

  2024cites this paper
• Long-Term Immunomodulatory Impact of VNS on Peripheral Cytokine Profiles and Its Relationship with Clinical Response in Difficult-to-Treat Depression (DTD)

  2024cites this paper
• Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets

  2024cites this paper
• Immunological correlates of suicidality among adolescents with internalizing symptoms

  2024cites this paper
• Plasma levels of hydrogen sulfide and homocysteine correlate with the efficacy of antidepressant agents and serve as potential diagnostic and therapeutic markers.

  2024cites this paper
• Association between neutrophil-to-lymphocyte ratio and specific depressive symptoms: an analysis of a population-based cross-sectional survey

  2024cites this paper
• Inflammation as a mediator between adverse childhood experiences and adult depression: A meta-analytic structural equation model.

  2024cites this paper
• A novel framework for ketamine-assisted couple therapy

  2024cites this paper
• Dysregulated cerebral blood flow, rather than gray matter Volume, exhibits stronger correlations with blood inflammatory and lipid markers in depression

  2024cites this paper
• Mucuna pruriens, a Possible Treatment for Depressive Disorders

  2024cites this paper
• GPR55 activation improves anxiety- and depression-like behaviors of mice during methamphetamine withdrawal

  2024cites this paper
• The intricate brain-body interaction in psychiatric and neurological diseases.

  2024cites this paper
• Association of inflammatory cytokines with magnetic resonance imaging features of the brain in patients with depression.

  2024cites this paper
• Opioid Mechanisms and the Treatment of Depression.

  2023cites this paper
• Psychedelics for treatment resistant depression: are they game changers?

  2023cites this paper
• Omega-3 Polyunsaturated Fatty Acids in Managing Comorbid Mood Disorders in Chronic Obstructive Pulmonary Disease (COPD): A Review

  2023cites this paper
• Being overweight and obese increases suicide risk, the severity of depression, and the inflammatory response in adolescents with major depressive disorders

  2023cites this paper
• C-reactive protein does not predict future depression onset in adolescents: preliminary findings from a longitudinal study

  2023cites this paper
• Niacin modulates depressive-like behavior in experimental colitis through GPR109A-dependent mechanisms.

  2023cites this paper
• The interaction between MC4R gene variant (rs17782313) and dominant dietary patterns on depression in obese and overweight women: a cross sectional study

  2023cites this paper
• Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study

  2023cites this paper
• Association between platelet to lymphocyte ratio and depression and symptom severity among adults in the United States: A cross-sectional study

  2023cites this paper
• Involvement of indoleamine 2, 3-dioxygenase (IDO) and brain-derived neurotrophic factor (BDNF) in the neuroprotective mechanisms of ferulic acid against depressive-like behaviour

  2023cites this paper
• Chemical profiles and pharmacological attributes of Apis cerana indica beehives using combined experimental and computer-aided studies.

  2023cites this paper
• Comorbidities in Psoriatic Arthritis: A Narrative Review.

  2023cites this paper
• Inflammation, stress and depression: an exploration of ketamine's therapeutic profile.

  2023cites this paper
• A Functional Account of Stimulation-based Aerobic Glycolysis and its Role in Interpreting BOLD Signal Intensity Increases in Neuroimaging Experiments.

  2023cites this paper
• Changes in neuroactive steroids, neurotrophins and immunological biomarkers after monotherapy 8-week rTMS treatment and their relationship with neurocognitive functions in depression

  2023cites this paper
• Emotional, inflammatory, and genetic factors of resilience and vulnerability to depression in patients with premenopausal breast cancer: A longitudinal study protocol

  2023cites this paper
• Associations of C-reactive protein with depressive symptoms over time after mild to moderate ischemic stroke in the PROSCIS-B cohort

  2023cites this paper
• The relationship between neutrophil lymphocyte ratio, platelet lymphocyte ratio, and depression in dialysis patients

  2023cites this paper
• Prospective network analysis of proinflammatory proteins, lipid markers, and depression components in midlife community women

  2022cites this paper
• Genomic-Analysis-Oriented Drug Repurposing in the Search for Novel Antidepressants

  2022cites this paper
• Integrated co-expression network analysis uncovers novel tissue-specific genes in major depressive disorder and bipolar disorder

  2022cites this paper
• Inflammatory markers and incident depression: Evidence in a population-based prospective study.

  2022cites this paper
• Major Depressive Disorder: Existing Hypotheses about Pathophysiological Mechanisms and New Genetic Findings

  2022cites this paper
• Reviewing the mitochondrial dysfunction paradigm in rodent models as platforms for neuropsychiatric disease research.

  2022cites this paper
• Association of Dietary Inflammatory Index (DII) and depression in the elderly over 55 years in Northern China: analysis of data from a multicentre, cohort study

  2022cites this paper
• Editorial: Vulnerability and protective factors for inflammation-associated somatoform and mental disorders.

  2022cites this paper
• Inflammatory Cytokines, but Not Dietary Patterns, Are Related to Somatic Symptoms of Depression in a Sample of Women

  2022cites this paper
• The Role of Natural Products in Treatment of Depressive Disorder

  2022cites this paper
• A Prospective Viewpoint on Neurological Diseases and Their Biomarkers

  2022cites this paper
• Impact of parasitic infection on mental health and illness in humans in Africa: a systematic review

  2022cites this paper
• Early-diagnosis of major depressive disorder: From biomarkers to point-of-care testing

  2022cites this paper
• Higher serum interleukin‐12 levels are associated with the pathophysiology of major depressive disorder: A case‐control study results

  2022cites this paper
• Vestibular migraine treatment: a comprehensive practical review

  2022cites this paper
• Impact of antidepressant treatment on complete blood count parameters and inflammatory ratios in adolescents with major depressive disorder.

  2022cites this paper
• Connecting the dots from east to west

  2022cites this paper
• Associations between the kynurenine pathway and the brain in patients with major depressive disorder-A systematic review of neuroimaging studies.

  2022cites this paper
• Pre-treatment plasma cytokine levels as potential predictors of short-term remission of depression

  2022cites this paper
• Combined repetitive transcranial magnetic stimulation and medication treatment for depression is associated with serum amyloid a level: Evidence from naturalistic clinical practice

  2022cites this paper
• Association between neutrophil to lymphocyte ratio and depression among US adults: From a large population-based cross-sectional study.

  2022cites this paper
• The clinical features and potential mechanisms of cognitive disorders in peripheral autoimmune and inflammatory diseases

  2022cites this paper
• Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease

  2022influential citation
• Therapeutic effect of Thymoquinone on behavioural response to UCMS and neuroinflammation in hippocampus and amygdala in BALB/c mice model

  2022cites this paper
• The interplay between tumor necrosis factor alpha, disease activity, and depressive symptoms among Egyptian female patients with systemic lupus erythematosus.

  2021cites this paper
• Medicinal Plants in the Treatment of Depression. II: Evidence from Clinical Trials

  2021cites this paper
• Association between dietary omega-3 fatty acid intake and depression in postmenopausal women

  2021cites this paper
• Immunity and Gilles de la Tourette syndrome: A systematic review and meta‐analysis of evidence for immune implications in Tourette syndrome

  2021cites this paper
• Gut microbiota determines the social behavior of mice and induces metabolic and inflammatory changes in their adipose tissue

  2021cites this paper
• Hypothalamic-Pituitary-End-Organ Axes: Hormone Function in Female Patients with Major Depressive Disorder

  2021cites this paper
• Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression

  2021cites this paper
• Measurement Invariance in the CESD-8 and Assessment of Mood Correlates Between American and Mexican Community Studies on the Multisystemic Geriatric Depression Cycle

  2021cites this paper
• Cardiovascular Disease Risk Factors Among Children and Adolescents With Depression

  2021cites this paper
• 19th Congress of the European Society for Dermatology and Psychiatry (ESDaP) and 2nd Brain Skin Colloquium Conference (BSC), June 11–13, 2021, London

  2021cites this paper
• Biological Evaluation of Aegle marmelos Fruit Extract and Isolated Aegeline in Alleviating Pain–Depression Dyad: In Silico Analysis of Aegeline on MAO-A and iNOS

  2021cites this paper
• Roles of Tumor Necrosis Factor-α and Tumor Necrosis Factor-α Receptor 2 in Inflammation-Related Diseases

  2021cites this paper
• Medicinal Plants in the Treatment of Depression: Evidence from Preclinical Studies

  2021cites this paper
• P2X7 Receptor as a Potential Target for Major Depressive Disorder.

  2021cites this paper
• Chemokines gene expression in the prefrontal cortex of depressed suicide victims and normal control subjects.

  2021cites this paper
• Ganoderma Lucidum Polysaccharides Ameliorated Depression-Like Behaviors in the Chronic Social Defeat Stress Depression Model via Modulation of Dectin-1 and the Innate Immune System.

  2021cites this paper
• Bariatric surgery alleviates depression in obese patients: A systematic review and meta-analysis.

  2021cites this paper
• [Locomotive syndrome: from paradigms to clinical reality].

  2021cites this paper
• The effect of the Standard American Diet on Iba-1 immunoreactivity in the spinal cord before and after peripheral inflammatory injury in rats

  2021cites this paper
• The role of AQP4 in the pathogenesis of depression, and possible related mechanisms.

  2021cites this paper
• Research Progress on Natural Compounds Exerting an Antidepressant Effect through Anti-inflammatory.

  2021cites this paper
• Lost in translation. The quest for definitions of treatment-resistant depression with a focus on inflammation-related gene expression

  2021cites this paper
• LENNA (Learning Emotions Neural Network Assisted): An Empathic Chatbot Designed to Study the Simulation of Emotions in a Bot and Their Analysis in a Conversation

  2021cites this paper
• [Characteristics of arterial hypertension clinical course in patients with obesity and anxiety-depressive disorders].

  2021cites this paper
• Efficacy of IV Immunoglobulins on Psychiatric Symptoms: A Case Report

  2021cites this paper
• Transcriptomic Signatures of Psychomotor Slowing in Peripheral Blood of Depressed Patients: Evidence for Immunometabolic Reprogramming

  2021cites this paper
• Potential depression and antidepressant-response biomarkers in human lymphoblast cell lines from treatment-responsive and treatment-resistant subjects: roles of SSRIs and omega-3 polyunsaturated fatty acids

  2020cites this paper
• A comparison study of metabolic profiles, immunity, and brain gray matter volumes between patients with bipolar disorder and depressive disorder

  2020cites this paper
• RMHP_A_266269 1293..1300

  2020cites this paper